Taiwan Bio Therapeutics Co., Ltd (TPEX:6892)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.35
-0.20 (-0.60%)
Jun 12, 2025, 1:46 PM CST
-12.12%
Market Cap 2.84B
Revenue n/a
Net Income n/a
Shares Out 84.61M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 42,811
Average Volume 113,680
Open 33.65
Previous Close 33.55
Day's Range 32.90 - 33.75
52-Week Range 26.90 - 59.87
Beta 0.31
RSI 65.79
Earnings Date n/a

About Taiwan Bio Therapeutics

Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6892
Full Company Profile

News

There is no news available yet.